concept

NEURONS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURONS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5006Connections

30Hypotheses

10Analyses

50Outgoing

50Incoming

3Experiments

20Debates

Summary

Neurons are the fundamental information-processing cells of the nervous system, transmitting electrical and chemical signals across synapses. The human brain contains approximately 86 billion neurons organized into circuits for perception, cognition, and motor control. Key subtypes include excitatory glutamatergic pyramidal neurons, inhibitory GABAergic interneurons (parvalbumin+, somatostatin+, VIP+), dopaminergic neurons (substantia nigra, VTA), and cholinergic neurons (basal forebrain). Selective neuronal vulnerability is a hallmark of neurodegeneration: entorhinal cortex layer II neurons in AD, dopaminergic neurons in PD, motor neurons in ALS, and medium spiny neurons in HD. Neuronal loss correlates more strongly with cognitive decline than amyloid plaques, driving interest in neuroprotective strategies.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	NEURONS
Key Genes/Proteins	3r-tau, 4r-tau, AB, ABCA1, ABCA7, ACHE
Related Diseases	acetylcholine, ACETYLCHOLINE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Spinal Cord Dorsal Horn Neurons

cell · 4424 words

→

Pathway Diagram

flowchart TD
    NEURONS["NEURONS"]
    PARKINSON["PARKINSON"]
    PARKINSON_S["PARKINSON'S"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    PARKIN(["PARKIN"])
    STING(["STING"])
    OPTN(["OPTN"])
    SPINAL_CORD["SPINAL CORD"]
    VCP(["VCP"])
    NEUROTRANSMISSION["NEUROTRANSMISSION"]
    PI3K(["PI3K"])
    REMYELINATION["REMYELINATION"]

    NEURONS -->|"activates"| PARKINSON
    NEURONS -->|"activates"| PARKINSON_S
    NEURONS -->|"activates"| PARKINSON_S_DISEASE
    NEURONS -->|"biomarker for"| PARKIN
    NEURONS -->|"biomarker for"| PARKINSON
    NEURONS -->|"biomarker for"| PARKINSON_S
    NEURONS -.->|"inhibits"| STING
    NEURONS -->|"causes"| OPTN
    NEURONS -->|"reduces"| SPINAL_CORD
    NEURONS -->|"expressed in"| SPINAL_CORD
    NEURONS -->|"activates"| VCP
    NEURONS -->|"contributes to"| VCP
    NEURONS -->|"stabilizes"| NEUROTRANSMISSION
    NEURONS -->|"activates"| PI3K
    NEURONS -.->|"inhibits"| REMYELINATION

    style NEURONS fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (1273)

Target	Relation	Type	Str
ds-f2c28aed24a7	data_in	dataset	1.00
ds-f2c28aed24a7	provides_data_for	dataset	1.00
Neurovascular Unit	component_of	process	0.95
Signal Transmission	involved_in	process	0.90
Network Integration	involved_in	process	0.90
Neurodegenerative Diseases	associated_with	disease	0.90
neurodegeneration	associated_with	disease	0.90
neurodegeneration	expressed_in	disease	0.90
neurodegeneration	activates	disease	0.90
neurodegeneration	causes	disease	0.90
ALS	causes	disease	0.90
Alzheimer's disease	activates	disease	0.90
neurodegeneration	regulates	disease	0.90
neuroinflammation	activates	disease	0.90
Alzheimer's disease	associated_with	disease	0.90
Premature Senescence	associated_with	phenotype	0.90
ALS	associated_with	disease	0.90
Neuroinflammation	involved_in	process	0.85
Synaptic Properties	expressed_in	phenotype	0.85
insulin signaling	active_in	pathway	0.85
epigenetic regulation	active_in	pathway	0.85
autophagy pathway	active_in	pathway	0.85
Antimicrobial peptides	expressed_in	protein	0.85
NAD+ metabolism	active_in	pathway	0.85
circadian regulation	active_in	pathway	0.85
neurotrophin signaling	active_in	pathway	0.85
mitochondrial function	active_in	pathway	0.85
cholesterol homeostasis	active_in	pathway	0.85
glutamate signaling	active_in	pathway	0.85
oxidative stress response	active_in	pathway	0.85
pyroptosis	active_in	pathway	0.85
brain-derived extracellular vesicles	mediates	compound	0.85
unfolded protein response	active_in	pathway	0.85
synaptic plasticity	active_in	pathway	0.85
Cancer Cells	interacts_with	cell_type	0.85
Alzheimer's disease	interacts_with	disease	0.80
ferroptosis	activates	process	0.80
neurodegeneration	inhibits	disease	0.80
pyroptosis	activates	process	0.80
Parkinson's disease	associated_with	disease	0.80
ALS	activates	disease	0.80
NEURODEGENERATIVE DISEASES	targets	disease	0.80
Proteasome Downregulation	expressed_in	process	0.80
tau phosphorylation	activates	process	0.80
neuroinflammation	regulates	disease	0.80
neurodegeneration	interacts_with	disease	0.80
PROTECTIVE EFFECTS	exerts	phenotype	0.80
mitochondrial dysfunction	mediates	process	0.80
Parkinson's Disease	associated_with	disease	0.80
neurodegeneration	implicated_in	process	0.80

Incoming (3733)

Source	Relation	Type	Str
cell-types-dendritic-spine-degeneration-neurons	describes	wiki	1.00
ds-f2c28aed24a7	data_in	dataset	1.00
Neuronal Surface Molecules	expressed_in	biomarker	0.95
opsin	activates	protein	0.95
Somatic Genomic Changes	associated_with	process	0.95
CX3CL1	interacts_with	protein	0.95
Epigenetic Modifications	involved_in	process	0.95
Mitochondrial Respiration	involved_in	process	0.95
SLC45A1	expressed_in	protein	0.95
Astrocytes	associated_with	cell_type	0.95
DNA	activates	gene	0.90
serotonin	released_by	neurotransmitter	0.90
BDNF	associated_with	gene	0.90
frontotemporal dementia	affects	disease	0.90
ALS	causes	gene	0.90
MAPK	expressed_in	gene	0.90
ALS	regulates	gene	0.90
autophagy pathway	active_in	pathway	0.90
RNA	expressed_in	gene	0.90
epilepsy	affects	disease	0.90
neurodegeneration	affects	disease	0.90
neuroinflammation	affects	disease	0.90
Parkinson's disease	affects	disease	0.90
Tat-NTS peptide	protects_against	compound	0.90
PS1	expressed_in	gene	0.90
Oxidized Phosphatidylcholines	targets	compound	0.90
ROS	expressed_in	gene	0.90
18688088	aggregates and deposits in	paper	0.90
DNA	interacts_with	gene	0.90
22735187	are critically dependent on	paper	0.90
anxiety	affects	disease	0.90
Alzheimer's disease	affects	disease	0.90
Optogenetics	activates	process	0.90
synaptic plasticity	active_in	pathway	0.90
ALS	activates	gene	0.90
mitochondrial dynamics	active_in	pathway	0.90
Hph-Rnpec	targets	drug	0.90
multiple sclerosis	affects	disease	0.90
BDNF	activates	gene	0.90
NF-kB signaling	active_in	pathway	0.90
28569837	revealed in	paper	0.90
31163285	transcribe	paper	0.90
RNA	activates	gene	0.90
27466127	release functional mitochondria that enter	paper	0.90
aging	affects	disease	0.90
38993123	targets	paper	0.90
purinergic receptor	expressed_in	receptor	0.90
APP	inhibits	gene	0.90
40791427	show decreased	paper	0.90
spinal muscular atrophy	affects	disease	0.90

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop transcranial focused ultrasound targeting EC-II	0.968	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop optogenetic targeting PV interneurons to restore	0.959	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II	0.955	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II parvalbumin interneurons to	0.869	alzheimers	Circuit-level neural dynamics in neurode
SFPQ Paralog Displacement Triggers Cryptic Polyadenylation a	0.864	als	-

Closed-loop focused ultrasound targeting EC-II PV interneuro	0.863	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo	0.827	alzheimers	Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe	0.827	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress	0.811	alzheimers	Circuit-level neural dynamics in neurode
TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress	0.810	als	-
MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs an	0.801	als	-
Closed-loop transcranial focused ultrasound targeting CA1 PV	0.797	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting entorhinal cortex layer II SST in	0.784	alzheimers	Circuit-level neural dynamics in neurode
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi	0.783	neurodegeneration	-
Exosomal SNCA Propagation from Lysosome-Compromised Neurons	0.777	neurodegeneration	-
STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Functio	0.760	als	Causal Sequence of TDP-43 Nuclear Cleara
Closed-loop focused ultrasound targeting CA1 PV interneurons	0.754	alzheimers	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t	0.752	alzheimers	Circuit-level neural dynamics in neurode
GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Switch in A9	0.750	neurodegeneration	-
Closed-loop focused ultrasound targeting EC-II SST interneur	0.748	alzheimers	Circuit-level neural dynamics in neurode
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi	0.720	neurodegeneration	What are the mechanisms by which gut mic
TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Ca	0.703	neurodegeneration	What mechanisms underlie neuronal resist
Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Rep	0.680	neurodegeneration	epigenetic reprogramming aging neurons
Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neu	0.680	neurodegeneration	What are the mechanisms by which gut mic
Microglial NOX2 establishes an inflammatory ROS propagation	0.680	neurodegeneration	What mechanisms drive the self-amplifyin
Dasatinib plus Quercetin Senolytic Clearance of p16Ink4a-Hig	0.680	neurodegeneration	-
OPTN/TBK1 mutations create selective vulnerability by blocki	0.670	neurodegeneration	What are the neuron-specific effects of
ISR/eIF2α~P Overflow Represses Synaptic Proteostasis in Cort	0.650	frontotemporal-dementia	-
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote	0.000	als	-
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T	0.000	als	What are the mechanisms by which microgl

Mentioning Analyses (10)

Scientific analyses that reference this entity

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

What determines blood-brain barrier penetration kinetics for specialized pro-res

neuropharmacology | 2026-04-13 | 2 hypotheses Top: 0.551

What are the molecular determinants that control directional mitochondrial trans

cellular neuroscience | 2026-04-12 | 0 hypotheses

Do tau aggregates represent protective responses or primary pathogenic drivers i

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (3)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn	clinical	Alzheimer's disease and relate	0.950	0.00	human patients	proposed	N/A
Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Int	in_vivo	Alzheimer's disease	0.765	0.55	APP/PS1 mice 8-11 months (n=10	abandoned	$125,000
tFUS Targeting EC-II SST Interneurons Restores Hippocampal-Prefrontal	in_vivo	Alzheimer's disease	0.744	0.48	hAPP-J20 mice (n=10/group x 3	abandoned	$110,000

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Retinal Müller glia alterations and their impact on ocular glymphatic clearance [PMID:41603340]	Das G, Raghunathan R, Wang L	J Alzheimers Dis	2026
The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, [PMID:41226584]	["Costea D", "Dobrin N", "Tataru C", "To	International journal of molec	2025
Longitudinal changes of blood-brain barrier and transcytolemmal water exchange p [PMID:40089221]	Xiong C, Yu Z, Yin Y	Neuroimage	2025
Targeting Neural Oscillations for Cognitive Enhancement in Alzheimer’s Disease [PMID:40142358]	Federica Palacino, P. Manganotti, A. Ben	{'name': 'Medicina', 'volume':	2025
The future of biomarkers for vascular contributions to cognitive impairment and [PMID:40542975]	Lennon MJ, Karvelas N, Ganesh A	Geroscience	2025
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667]	Zhang D, Zhang W, Ming C, Gao X, Yuan H,	Neuron	2024
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117]	Balusu S, De Strooper B	Acta neuropathologica	2024
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890]	Burillo J, Marqués P, Jiménez B, Gonzále	Cells	2021
Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Bur [PMID:34958021]	M. Dhaynaut, G. Sprugnoli, D. Cappon	{'name': "Journal of Alzheimer	2021
Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasou [PMID:32999351]	Lee Y, Choi Y, Park EJ	Sci Rep	2020
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169]	["Oakley, Holly", "Cole, Sarah L", "Loga	The Journal of neuroscience :	2006
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773]	["Hardy, John", "Selkoe, Dennis J"]	Science (New York, N.Y.)	2002

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Chromatin Remodeling-Mediated Nutrient Sensing Restoration

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27